en
svPress releases
Regulatory press release 2019-06-11
Xspray granted additional product patents in the United States for HyNap-Sora and HyNap-Nilo
Press release 2019-05-23
Bulletin from the annual general meeting of Xspray Pharma AB (publ)
Press release 2019-05-16
Xspray Pharma publishes Interim Report Q1, January-March 2019
Press release 2019-05-03
Kerstin Hasselgren appointed CFO at Xspray Pharma
Press release 2019-04-24
Notice of annual general meeting of Xspray Pharma AB (publ)
Regulatory press release 2019-02-18
Xspray Pharma announces positive clinical data for the drug candidate HyNap-Sora
Press release 2019-02-14
Xspray Pharma publishes its Year-end Report, January – December 2018
Regulatory press release 2018-12-06
Xspray Pharma has carried out a directed share issue raising gross proceeds of approximately SEK 92 million
Regulatory press release 2018-12-06
Xspray Pharma contemplates a directed share issue to continue development of its product portfolio
Regulatory press release 2018-12-04